CHRISTIAN S SCHADE
CIK 1214496 · Chairman & CEO · last filed 2026-05-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.82M
Companies
5
Total Filings
47
Lifetime Open-Market Net
-$2.43M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IART | Director | 90,034 | $16.49 | $1.48M | -$2.54M | 25 | 2026-05-11 |
| Omega Therapeutics, Inc. (OMGA) Delisted | Director | — | $0.14 | — | $0 | 4 | 2024-06-21 |
| APRE | Chairman & CEO | 13,212 | $0.64 | $8.5K | $114.1K | 8 | 2022-08-01 |
| NRG | Exec VP & Chief Financial Ofc | 34,916 | $123.95 | $4.33M | $0 | 2 | 2011-03-30 |
| MEDX | SVP & CFO | 0 | $35.60 | $0 | $0 | 5 | 2009-08-31 |
Recent Filings · Page 3 of 5
47 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-05-14 | IART | Mixed | — | -$463.4K | EDGAR |
| 2018-05-21 | IART | Grant (A) | +2,965 | $0 | EDGAR |
| 2018-03-06 | IART | Mixed | — | -$545.2K | EDGAR |
| 2017-05-25 | IART | Grant (A) | +3,544 | $0 | EDGAR |
| 2016-05-26 | IART | Grant (A) | +2,341 | $0 | EDGAR |
| 2016-05-05 | IART | Mixed | — | -$228.7K | EDGAR |
| 2015-05-27 | IART | Grant (A) | +2,296 | $0 | EDGAR |
| 2015-05-18 | IART | Other (J) | −6,657 | $0 | EDGAR |
| 2014-02-28 | IART | Mixed | — | -$166.8K | EDGAR |
| 2013-07-18 | — | Mixed | −25,601 | $657.9K |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.